CICERI, FABIO

CICERI, FABIO  

Facoltà di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 881 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia 1-gen-2017 Piemontese, S.; Ciceri, F.; Labopin, M.; Arcese, W.; Kyrcz-Krzemien, S.; Santarone, S.; Huang, H.; Beelen, D.; Gorin, N. C.; Craddock, C.; Gulbas, Z.; Bacigalupo, A.; Mohty, M.; Nagler, A.
A dual role for genetically modified lymphocytes in cancer immunotherapy 1-gen-2012 Russo, V; Bondanza, Attilio; Ciceri, Fabio; Bregni, M; Bordignon, Claudio; Traversari, C; Bonini, MARIA CHIARA
A glimpse into the in vivo dynamics during immune reconstitution in ADA-SCID patients after gene therapy treatment 1-gen-2009 Selleri, S; Scaramuzza, S; Brigida, I; Biasco, L; Casiraghi, M; Ferrua, F; Ciceri, Fabio; Marktel, S; Cappelli, B; Roncarolo, Mg; Aiuti, A.
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study 1-gen-2021 Mohty, M.; Battista, M. L.; Blaise, D.; Calore, E.; Cesaro, S.; Maximova, N.; Perruccio, K.; Renard, C.; Wynn, R.; Zecca, M.; Labopin, M.; Hanvesakul, R.; Amber, V.; Ryan, R. J.; Lawson, S.; Ciceri, F.
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 1-gen-2017 Forcina, Alessandra; Rancoita, Paola Maria Vittoria; Marcatti, Magda; Greco, Raffaella; Lupo-Stanghellini, Maria Teresa; Carrabba, Matteo; Marasco, Vincenzo; Di Serio, Clelia; Bernardi, Massimo; Peccatori, Jacopo; Corti, Consuelo; Bondanza, Attilio; Ciceri, Fabio
A new suicide system based on gene transfer of FAS into donor lymphocytes for controlled GVL. 1-gen-1998 Marktel, S; Ciceri, Fabio; Bonini, MARIA CHIARA; Thomis, D; Amara, Jf; Zappone, E; Servida, P; Rossini, S; Traversari, C; Gilman, M; Bordignon, Claudio
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 1-gen-2017 Ahci, Müberra; Toffalori, Cristina; Bouwmans, Evelien; Crivello, Pietro; Brambati, Chiara; Pultrone, Cinzia; Stempelmann, Karin; Bost, Douglas; Mazzi, Benedetta; Beelen, Dietrich W; Ciceri, Fabio; Mulder, Wietse; Fleischhauer, Katharina; Vago, Luca
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 1-gen-2022 De Lorenzo, Rebecca; Magnaghi, Cristiano; Cinel, Elena; Vitali, Giordano; Martinenghi, Sabina; Mazza, Mario G; Nocera, Luigi; Cilla, Marta; Damanti, Sarah; Compagnone, Nicola; Ferrante, Marica; Conte, Caterina; Benedetti, Francesco; Ciceri, Fabio; Rovere-Querini, Patrizia
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 1-gen-2022 Migliavacca, Maddalena; Basso Ricci, Luca; Farinelli, Giada; Calbi, Valeria; Tucci, Francesca; Barzaghi, Federica; Ferrua, Francesca; Cicalese, Maria Pia; Darin, Silvia; Barzaghi, Lina Raffaella; Giglio, Fabio; Peccatori, Jacopo; Fumagalli, Francesca; Nicoletti, Roberto; Giannelli, Stefania; Sartirana, Claudia; Bandiera, Alessandro; Esposito, Maria; Milani, Raffaella; Mazzi, Benedetta; Finocchi, Andrea; Marktel, Sarah; Assanelli, Andrea; Locatelli, Franco; Ciceri, Fabio; Aiuti, Alessandro; Bernardo, Maria Ester
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 1-gen-2016 Brigida, I; Scaramuzza, S; Lazarevic, D; Cittaro, D; Ferrua, F; Leonardelli, L; Alessio, M; Forma, O; Lanzani, C; Viarengo, G; Ciceri, Fabio; Jankovic, M; Pesce, F; Aiuti, Alessandro; Cicalese, Mp
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 1-gen-2014 Lepore, M; de Lalla, C; Gundimeda, Sr; Gsellinger, H; Consonni, M; Garavaglia, C; Sansano, S; Piccolo, F; Scelfo, A; Haussinger, D; Montagna, D; Locatelli, F; Bonini, MARIA CHIARA; Bondanza, Attilio; Forcina, A; Li, Zy; Ni, Gh; Ciceri, Fabio; Jeno, P; Xia, Cf; Mori, L; Dellabona, P; Casorati, G; De Libero, G.
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 1-gen-2022 Pierini, Valentina; Bardelli, Valentina; Giglio, Fabio; Arniani, Silvia; Matteucci, Caterina; Pellanera, Fabrizia; Quintini, Martina; Crescenzi, Barbara; Bruno, Alessandro; Sabattini, Elena; Falcinelli, Emanuela; Ruggeri, Loredana; Ronchi, Paola; Ponzoni, Maurilio; Ciceri, Fabio; Mecucci, Cristina; La Starza, Roberta
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 1-gen-2004 Bonini, MARIA CHIARA; Ciceri, Fabio; Lupo Stanghellini, Mt; Bondanza, Attilio; Magnani, Z; Perna, Sk; Bernardi, M; Peccatori, J; Pescarollo, A; Crippa, F; Callegaro, L; Salomoni, M; Turchetto, L; Toma, S; Aversa, F; Apperley, J; Slavin, S; Colombi, S; Stampino, Cg; Bregni, M; Bordignon, Claudio
A PHASE II STUDY ON INTENSIVE ALL TYPE CHEMOTHERAPY WITH MINIMAL RESIDUAL DISEASE (MRD) ORIENTED POSTREMISSION STRATEGY IN ADULT PATIENTS WITH LYMPHOBLASTIC LYMPHOMA (PROTOCOL NILG-ALL NO. 09/00) 1-gen-2008 Cortelazzo, Sc; Intermesoli, T; Oldani, E; Ciceri, Fabio; Rossi, G; Pogliani, E; Gallamini, A; Romani, C; Cortelezzi, A; Rambaldi, A; Bassan, R.
A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens 1-gen-2008 Cavo, M; Palumbo, A; Bringhen, S; Falcone, A; Musto, P; Ciceri, Fabio; Grasso, M; Zambello, R; Petti, Mc; Ciambelli, F; De Sabbata, G; Rocco, S; Gugliotta, L; Gherlinzoni, F; D'Arco, A; Martelli, M; Guglielmelli, T; Tacchetti, P; Baccarani, M; Boccadoro, M.
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 1-gen-2015 Milan, E; Perini, T; Resnati, M; Orfanelli, U; Oliva, L; Raimondi, A; Cascio, P; Bachi, A; Marcatti, M; Ciceri, Fabio; Cenci, S.
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 1-gen-2006 Bacigalupo, A; van Lint, Mt; Olivieri, A; Casini, M; Angelucci, E; Narni, F; Selleri, C; Di Bartolomeo, P; Ciceri, Fabio; Fanin, R.
A randomized trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants. 1-gen-2006 Bacigalupo, A; Lamparelli, T; Ciceri, Fabio; Peccatori, F; Locasciulli, A; Majolino, I; Di Bartolomeo, P; Milone, G; Mazza, P; Lacopino, P; Sacchi, N; van Lint, Mt
A recent update of 3 consecutive prospective trials with high-dose therapy and autograft, without or with rituximab, as primary treatment for advanced-stage follicular lymphoma shows a sizeable group of patients surviving in continuous complete remission 1-gen-2010 Tarella, C; Ladetto, M; Benedetti, F; Vitolo, U; Pulsoni, A; Patti, C; Callea, V; Rambaldi, A; Piccin, A; Devizzi, L; Musso, M; Iannitto, E; Spedini, P; Liberati, Am; Ciceri, Fabio; Gallamini, A; Rodeghiero, F; Gini, G; De Crescenzo, A; Di Raimondo, F; Levis, A; Chisesi, T; Petrone, T; Scalabrini, Dr; Rossi, G; Carella, Am; Parvis, G; Majolino, I; Passera, R; Ruella, M; Pileri, A; Gianni, Am; Corradini, P.
A Recent Update of Three Consecutive Prospective Trials with High-Dose Therapy and Autograft, without or with Rituximab, as Primary Treatment for Advanced-Stage Follicular Lymphoma (FL) Shows a Sizeable Group of Patients Surviving in Continuous Complete Remission up to 16 Years After the End of Treatment: Should We Still Consider FL An Incurable Disease ? 1-gen-2009 Tarella, C; Ladetto, M; Benedetti, F; Vitolo, U; Pulsoni, A; Patti, C; Callea, V; Rambaldi, A; Piccin, A; Magni, M; Musso, M; Iannitto, E; Spedini, P; Liberati, Am; Ciceri, Fabio; Gallamini, A; Rodeghiero, F; Gini, G; De Crescenzo, A; Di Raimondo, F; Levis, A; Chisesi, T; Perrone, T; Scalabrini, Dr; Rossi, G; Carella, Am; Parvis, G; Majolino, I; Passera, R; Ruella, M; Pileri, A; Gianni, A; Corradini, P.